Gone but by no means forgotten

It is with great regret that we must report the demise — last Saturday — of Dr. Gerald (“Gerry”) Chodak — formerly a professor of urology at the University of Chicago Pritzker School of Medicine. … READ MORE …

What did the patient actually die of?

Two questions that come up regularly are whether: (a) men who are said to have died of prostate cancer actually did, and (b) men with prostate cancer who are said to have died of something else actually died of their prostate cancer. … READ MORE …

Radium-223 + abiraterone acetate: a potential safety issue

Bayer is to unblind data early from an ongoing randomized clinical trial of radium-223 acetate — on the guidance of the trial’s Independent Data Monitoring Committee (IDMC). … READ MORE …

This may put the cat among the pigeons!

A large, newly published, observational study has suggested that comorbidity affects other-cause mortality but not prostate cancer-specific mortality after accounting for patient and tumor characteristics and treatment type. … READ MORE …

Alternative medicine in the treatment of cancer (prostate cancer included)

There are very few good and thorough clinical studies on the use and the long-term effectiveness or efficacy of alternative forms of medicine in the treatment of cancer (let alone the treatment of prostate cancer specifically). … READ MORE …

This isn’t nice … it isn’t “fair” … but it’s true … and it’s important …

According to an article from Kaiser Health News on the CNN web site today, “People with advanced cancer don’t know enough about their disease to make informed decisions about treatment or how they want to spend their remaining time.” … READ MORE …

Time to death among men with nmCRPC by NCCN risk group

One of the abstracts to be presented at ASCO this year gives us some insight into risk for and time to death among men with non-metastatic but castration-resistant prostate cancer (nmCRPC). … READ MORE …

Aspirin use and risk for lethal prostate cancer

New data derived from the Physicans’ Health Study have suggested that there is an association between regular aspirin use and avoidance of risk for lethal forms of prostate cancer. … READ MORE …

Estimating overall survival for prostate cancer patients

It’s a question every prostate cancer patient wants an answer to: “OK doc. I get it. But how long am I gonna live with this?”

It’s also a question that doctors have a very great deal of difficulty answering, for a whole bunch of reasons. So … READ MORE …

The human capacity for denial … or at the very least avoidance

Your sitemaster is intimately familiar with the human capacity for denial and avoidance. As someone who has spent much of his life writing for a living, he knows all too well his capacity for avoiding some topics until he absolutely has to deal with them! … READ MORE …

Clinical and therapeutic histories of men who actually die of mCRPC

Despite all the prostate cancer research over the past 30 or so years, we still have limited information about the clinical and therapeutic history of prostate cancer in men who have progressive disease and go on to die of metastatic, castration-resistant prostate cancer (mCRPC). … READ MORE …

When to start planning for end-of-life care and death from prostate cancer

Alas, as most of our readers are all too well aware, some 30,000 or more men in America will die from prostate cancer this year and next year and on into the future, unless and until we find some radically new types of treatment. However, … READ MORE …

After 10 years, risk of prostate cancer-specific mortality lower for high-risk patients

A paper presented at the annual meeting of the European Association of Urology (EAU) suggests that high-risk prostate cancer patients < 60 years of age at the time of radical prostatectomy are more likely to die from their cancer than from other causes during the first 10 years after their surgery. But after that, other causes of death become more likely. … READ MORE …

Is smoking causing 15 to 25 percent of prostate cancer-specific deaths each year?

A new paper just published in European Urology offers further evidence from a meta-analysis of data from 51 different primary papers that smoking tobacco does increase a man’s risk of dying from prostate cancer — by about 24 percent compared to the risk for non-smokers. … READ MORE …

Prostate cancer mortality rates in the UK drop by 21 percent

According to a report in the Daily Telegraph, Cancer Research UK is claiming that deaths from prostate cancer in the UK have drop by 20.8 percent during the 19-year period from 1991-93 to 2010-12. … READ MORE …